Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Ludwig

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Genes & Development|November 3, 2010
Cytoplasmic ASPP1 inhibits apoptosis through the control of YAPArnaud M Vigneron, Robert L Ludwig, Karen H Vousden
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2012
Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell deathEric C Cheung, Robert L Ludwig, Karen H Vousden
The EMBO Journal|November 17, 2011
Regulation of p53 stability and function by the deubiquitinating enzyme USP42Andreas K Hock, Arnaud M Vigneron, Stephanie Carter, et al.
Oncogene|February 3, 2005
HDM2 phosphorylation by MAPKAP kinase 2Hans Oliver Weber, Robert L Ludwig, Deborah Morrison, et al.
Cancer Cell|July 5, 2003
Regulation of HDM2 activity by the ribosomal protein L11Marion A E Lohrum, Robert L Ludwig, Michael H G Kubbutat, et al.
Bioorganic & Medicinal Chemistry|October 27, 2006
Synthesis of 5-deazaflavin derivatives and their activation of p53 in cellsJennifer M Wilson, Graham Henderson, Fiona Black, et al.
Oncogene|April 18, 2002
Phosphorylation of HDM2 by AktMargaret Ashcroft, Robert L Ludwig, Douglas B Woods, et al.
Cancer Cell|June 14, 2005
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cellsYili Yang, Robert L Ludwig, Jane P Jensen, et al.
Cell|January 13, 2010
Mutant p53 drives invasion by promoting integrin recyclingPatricia A J Muller, Patrick T Caswell, Brendan Doyle, et al.
Cancer Research|October 3, 2007
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeuticsYili Yang, Jirouta Kitagaki, Ren-Ming Dai, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Genes & Development|November 3, 2010
Cytoplasmic ASPP1 inhibits apoptosis through the control of YAPArnaud M Vigneron, Robert L Ludwig, Karen H Vousden
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2012
Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell deathEric C Cheung, Robert L Ludwig, Karen H Vousden
The EMBO Journal|November 17, 2011
Regulation of p53 stability and function by the deubiquitinating enzyme USP42Andreas K Hock, Arnaud M Vigneron, Stephanie Carter, et al.
Oncogene|February 3, 2005
HDM2 phosphorylation by MAPKAP kinase 2Hans Oliver Weber, Robert L Ludwig, Deborah Morrison, et al.
Cancer Cell|July 5, 2003
Regulation of HDM2 activity by the ribosomal protein L11Marion A E Lohrum, Robert L Ludwig, Michael H G Kubbutat, et al.
Bioorganic & Medicinal Chemistry|October 27, 2006
Synthesis of 5-deazaflavin derivatives and their activation of p53 in cellsJennifer M Wilson, Graham Henderson, Fiona Black, et al.
Oncogene|April 18, 2002
Phosphorylation of HDM2 by AktMargaret Ashcroft, Robert L Ludwig, Douglas B Woods, et al.
Cancer Cell|June 14, 2005
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cellsYili Yang, Robert L Ludwig, Jane P Jensen, et al.
Cell|January 13, 2010
Mutant p53 drives invasion by promoting integrin recyclingPatricia A J Muller, Patrick T Caswell, Brendan Doyle, et al.
Cancer Research|October 3, 2007
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeuticsYili Yang, Jirouta Kitagaki, Ren-Ming Dai, et al.
Pageof 2